Breast implant incision options: access, scars, sensation, and future surgery

The three common breast-augmentation access routes are inframammary, through the fold beneath the breast; periareolar, along part of the areola border; and transaxillary, through the underarm. None is universally scarless or best. Incision choice affects the route to the pocket, tissue crossed, surgical exposure, scar location, possible sensory or lactation effects, device compatibility, and how future surgery may be approached.¹²³

The comparison should begin with an access map. A hidden scar in one view may require a longer working distance, cross different tissue, or make a later operation less direct. A visible line on a diagram does not predict how an individual scar will mature.

Three doors lead to different working angles

FDA patient labeling for one current implant family depicts these three locations, while FDA’s main labeling index directs readers to the exact approved device materials.¹² The diagram confirms available routes for that product context; it does not rank them for every implant or patient.

This page keeps three other decisions outside its boundary. Fill material belongs to the saline-versus-silicone guide. Pocket plane belongs to the over-versus-under-muscle guide. Implant dimensions require their own measurements. An incision should not be marketed as proof that any of those separate choices is correct.

Scar visibility is a scene, not a yes-or-no field

Inframammary scars may sit in a natural fold but can be seen when the breast is lifted, when lying down, or if the fold changes. Periareolar scars use a color transition but may be noticeable when pigment contrast, scar width, or healing differs. Transaxillary scars avoid a breast-surface scar but remain in the underarm, where sleeveless clothing, arm elevation, hair removal, sweat, and natural creases change visibility.

Ask to review scars in the positions that matter to the person—not only a straight-on photograph with arms down. Useful views include arms raised, side profile, lying position when available, and the types of garments the person expects to wear.

Scar quality also depends on genetics, skin tension, infection, wound separation, pigment change, sun exposure, location, and aftercare. No access route can guarantee an invisible line. If a practice promises “scarless augmentation,” ask where the incision actually is and which scars a later revision could add.

Sensation evidence does not produce a universal winner

Breast augmentation can change nipple, areola, breast-skin, or scar sensation through incision, dissection, stretch, swelling, or nerve injury. The 2026 scoping review found heterogeneous approaches and measurement methods; persistent changes were generally uncommon in the included literature, but the evidence did not establish a simple incision hierarchy for every patient.³

That uncertainty should appear in consent. Ask the surgeon to identify sensory nerves at risk along the planned route, whether baseline sensation is documented, when sensation is reassessed, and how temporary numbness, hypersensitivity, painful sensation, or a persistent change is handled.

Implant size relative to the tissue envelope may matter as much as the skin incision because tissue stretch can affect sensation. Incision comparisons that do not account for implant, pocket, technique, follow-up, and baseline measurement can misattribute the outcome.

Lactation is broader than the skin entry point

Breastfeeding after augmentation depends on preexisting gland development, pregnancy and birth factors, milk production, ducts and nerves, implant operation, complications, and the definition of “success.” The available meta-analysis included only a small group of comparative studies. It reported lower breastfeeding and exclusive-breastfeeding rates overall among participants with implants, while its incision subgroup did not establish that periareolar access reduced exclusive breastfeeding compared with inframammary access.⁵

That is not proof that incision never matters. The estimate was imprecise, procedures varied, and exclusive breastfeeding is not the same endpoint as any milk production or feeding with supplementation. A future-lactation discussion should record planned tissue dissection and nipple-areola work, not infer the entire answer from the external scar.

If a lift or reduction is also proposed, the operation changes substantially because skin, gland, pedicle, and nipple position may be altered. The lift-versus-implant guide owns that separate position-versus-volume decision.

Contracture studies are associations, not an incision verdict

A 2018 meta-analysis of seven comparative studies reported a higher pooled capsular-contracture association for periareolar incisions versus the combined alternatives and versus inframammary access in a subgroup, but not versus transaxillary access; the authors called for longer and higher-quality research.⁴ The studies cannot isolate incision from implant surface, pocket, operative technique, antibiotic practices, follow-up, surgeon, and era.

It would therefore be too strong to say that one incision “prevents” contracture or that another “causes” it. Once firmness, pain, or distortion exists, evaluation belongs to the capsular-contracture guide, not to a retrospective argument about the original scar.

Device and operation constraints must be named

An access route must accommodate the exact implant without relying on damaging force or an unapproved handling claim. Device dimensions, fill, shell, insertion instructions, and surgeon technique can affect the incision length and feasibility. Product labeling should be checked for the proposed model rather than generalized from another manufacturer’s diagram.¹

The rest of the operation matters too. A surgeon may prefer an incision because it gives direct visualization for a planned pocket, fold adjustment, bleeding control, or implant insertion. Transaxillary surgery may use visualization technology and specific instruments. Periareolar access depends partly on areola size and planned path. Prior scars, breast operations, radiation, asymmetry, or a revision can narrow the options.

Conversion is not automatically a complication; it can be a contingency when exposure, bleeding control, tissue quality, or device passage differs from the preoperative forecast. Consent should state when the surgeon might add or extend an incision and how that decision would be documented. The useful distinction is between a planned alternative that protects the operation and an unexpected scar with no prior explanation. Ask whether the quoted facility time, aftercare, and scar plan still apply if conversion occurs.

Future re-entry deserves its own line

Breast implants are not lifetime devices, and later surgery may be considered for rupture, malposition, contracture, size preference, tissue change, or another finding.¹ The original incision may be reopened, extended, or supplemented by a different incision depending on the required work.

Ask which future maneuvers can reasonably use the proposed route. A direct fold incision may facilitate some pocket revisions; an axillary scar does not guarantee all future work can avoid the breast; a periareolar incision may overlap with a future lift design but does not determine that design. No surgeon can promise the exact needs of an unknown future operation, but the likely access tradeoff can be recorded now.

Compare routes with an access-and-exit plan

1. Mark all three scars on the body and in photographs. Review visibility with arms down and raised, in profile, and in relevant clothing rather than using the word hidden.
2. Trace the working path. Document tissue crossed, visualization, pocket access, fold control, bleeding control, and device insertion for each feasible route.
3. Add person-specific constraints. Include areola size, fold position, prior scars, asymmetry, skin behavior, baseline sensation, lactation goals, and planned implant model.
4. Read evidence at its true strength. Keep observational contracture findings, heterogeneous sensation data, and limited breastfeeding evidence qualified.
5. Plan for conversion and later re-entry. State when another incision could be needed during the operation and how likely future revision work may change the scar map.

The strongest incision explanation is not “this scar is invisible.” It is: this route gives the required access for this device and operation, places the scar here, creates these tissue and evidence tradeoffs, and leaves this realistic pathway for future care.